Assignee profile:

E. R. Squibb & Sons, L.L.C.

City:

Princeton, New Jersey

Country:

United States

Published Applications:

23

Last publication date:

2017-11-30

Patent Grants:

23

Last grant date:

2019-12-10

Top Inventors for applications by E. R. Squibb & Sons, L.L.C.

These are the the leading inventors for applications assigned to E. R. Squibb & Sons, L.L.C.:

Recent patent applications by E. R. Squibb & Sons, L.L.C.

E. R. Squibb & Sons, L.L.C. based in Princeton, US has been assigned the rights to these inventions. The list includes both Pending Applications and Patent Grants:

#1 | 2017-11-30 ✅ Patent 10,501,556 granted on 2019-12-10
US20170342165A1
Chemistry; metallurgy

Compositions and methods for treating cocaine-related disorders

#2 | 2017-04-13 ✅ Patent 10,448,622 granted on 2019-10-22
US20170099814A1
Human necessities

Human artificial chromosome containing human antibody lambda light chain gene and non-human animal containing the human artificial chromosome capable of genetic transmission

#3 | 2016-08-04 ✅ Patent 10,155,813 granted on 2018-12-18
US20160222114A1
Chemistry; metallurgy

Fully human antibodies to BTLA

#4 | 2016-06-16 ✅ Patent 9,988,453 granted on 2018-06-05
US20160168249A1
Chemistry; metallurgy

Human monoclonal antibodies to O8E

#5 | 2016-03-03 ✅ Patent 9,580,467 granted on 2017-02-28
US20160060294A1
Chemistry; metallurgy

Antiproliferative compounds, conjugates thereof, methods therefor, and uses thereof

#6 | 2016-01-28 ✅ Patent 9,631,025 granted on 2017-04-25
US20160024221A1
Chemistry; metallurgy

Human monoclonal antibodies to fucosyl-GM1 and methods for using anti-fucosyl-GM1 antibodies

#7 | 2015-09-03 ✅ Patent 9,573,999 granted on 2017-02-21
US20150246972A1
Chemistry; metallurgy

CTLA-4 antibody dosage escalation regimens

#8 | 2014-12-25 ✅ Patent 9,426,970 granted on 2016-08-30
US20140380515A1
Human necessities

Transgenic transchromosomal rodents for making human antibodies

#9 | 2014-10-30 ✅ Patent 9,226,974 granted on 2016-01-05
US20140323690A1
Human necessities

Antiproliferative compounds, conjugates thereof, methods therefor, and uses thereof

#10 | 2014-07-17 ✅ Patent 9,765,141 granted on 2017-09-19
US20140199328A1
Chemistry; metallurgy

Methods for preparing interferon alpha antibodies

#11 | 2014-07-03 ✅ Patent 9,217,033 granted on 2015-12-22
US20140186892A1
Chemistry; metallurgy

Monoclonal antibodies against Glypican-3

#12 | 2014-05-01 ✅ Patent 9,217,029 granted on 2015-12-22
US20140120614A1
Chemistry; metallurgy

Antibodies against clostridium difficile toxins and uses thereof

#13 | 2014-01-16 ✅ Patent 9,346,882 granted on 2016-05-24
US20140017255A1
Chemistry; metallurgy

Fully human antibodies to BTLA

#14 | 2013-09-26 ✅ Patent 10,106,615 granted on 2018-10-23
US20130251729A1
Chemistry; metallurgy

Nucleic acids encoding human monoclonal antibodies that bind CXCR4

#15 | 2013-09-05 ✅ Patent 9,453,077 granted on 2016-09-27
US20130230534A1
Chemistry; metallurgy

Interferon receptor 1 antibodies and their uses

#16 | 2013-06-06 ✅ Patent 9,138,475 granted on 2015-09-22
US20130142789A1
Human necessities

Human monoclonal antibodies to Fucosyl-GM1 and methods for using anti-Fucosyl-GM1 antibodies

#17 | 2012-10-25 ✅ Patent 9,220,244 granted on 2015-12-29
US20120272344A1
Human necessities

Transgenic animals expressing chimeric antibodies for use in preparing human antibodies

#18 | 2012-08-30 ✅ Patent 9,102,738 granted on 2015-08-11
US20120219557A1
Chemistry; metallurgy

Human monoclonal antibodies to protein tyrosine kinase 7 (PTK7)

#19 | 2012-08-16 ✅ Patent 9,505,845 granted on 2016-11-29
US20120207764A1
Chemistry; metallurgy

Treating lung cancer using human monoclonal antibodies to protein tyrosine kinase 7 (PTK7)

#20 | 2012-02-23 ✅ Patent 9,693,539 granted on 2017-07-04
US20120047585A1
Human necessities

HCO32 and HCO27 and related examples

#21 | 2010-02-11 ✅ Patent 9,260,514 granted on 2016-02-16
US20100034818A1
Chemistry; metallurgy

Methods of treating conditions caused by increased expression of nerve growth factor (NGF) or increased sensitivity to NGF using anti-NGF neutralizing antibodies as selective NGF pathway inhibitors

#22 | 2008-12-25 ✅ Patent 9,499,838 granted on 2016-11-22
US20080317743A1
Human necessities

Human artificial chromosome containing human antibody λ light chain gene and non-human animal containing the human artificial chromosome capable of genetic transmission

#23 | 2007-12-06 ✅ Patent 9,758,593 granted on 2017-09-12
US20070280934A1
Chemistry; metallurgy

Compositions and methods for treating cocaine-related disorders

Also check out E. R. SQUIBB & SONS, L.L.C.'s (Princeton, United States) applicant profile with 16 patent applications submitted.

AssigneeID:

496796 ⎘